APOB and metabolic dysfunction-associated steatotic liver disease: The inhibitory role of Shenxiang Suhe Pill in liver fat and lipid accumulation may be played by the components in Atractylodes that can improve IR status while promoting lipid metabolism and inhibiting hepatic fat accumulation, thereby reducing hepatic steatosis.[10] In NAFLD patients, the levels of CD36 in the liver tissue increased, and the levels of apo B100 that was closely correlated with the fat content in liver tissue decreased.